Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 2002 May;56(5):349–353. doi: 10.1136/jech.56.5.349

Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users

A Bouhnik 1, J Moatti 1, D Vlahov 1, H Gallais 1, P Dellamonica 1, Y Obadia 1
PMCID: PMC1732133  PMID: 11964431

Abstract

Design: Longitudinal analysis including baseline and last follow up characteristics using generalised estimating equations (GEE).

Setting: Hospital departments for specialist AIDS care in south eastern France and inner suburbs of Paris.

Patients: All patients antiretrovial treatment naive, who reported being sexually active at enrolment, and who had at least one follow up visit in the cohort between October 1996 and May 1998 (n=188).

Main results: Of the 188 HIV infected IDUs who were antiretroviral treatment naive at enrolment, 34 were prescribed HAART during follow up. Proportion of patients who reported at least one episode of unprotected sexual intercourse in the previous six months only significantly decreased in the HAART treated group (from 47.1% to 23.5%, p=0.008, compared with 43.5% to 35.7% in the rest of the sample, p=0.10). GEE multivariate model confirmed that prescription of HAART was associated with reduced sexual risk.

Conclusions: The concern that HAART might result in clinical improvement leading to resumption of high risk activities that could inadvertently result in HIV transmission was not supported by these data. Reasons for further reductions in HIV risk with taking HAART remain to be clarified.

Full Text

The Full Text of this article is available as a PDF (115.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carrieri M. P., Moatti J. P., Vlahov D., Obadia Y., Reynaud-Maurupt C., Chesney M. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. J Epidemiol Community Health. 1999 Jan;53(1):4–8. doi: 10.1136/jech.53.1.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Catchpole M. A., Mercey D. E., Nicoll A., Rogers P. A., Simms I., Newham J., Mahoney A., Parry J. V., Joyce C., Gill O. N. Continuing transmission of sexually transmitted diseases among patients infected with HIV-1 attending genitourinary medicine clinics in England and Wales. BMJ. 1996 Mar 2;312(7030):539–542. doi: 10.1136/bmj.312.7030.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Deeks S. G., Smith M., Holodniy M., Kahn J. O. HIV-1 protease inhibitors. A review for clinicians. JAMA. 1997 Jan 8;277(2):145–153. [PubMed] [Google Scholar]
  4. Elford J., Bolding G., Maguire M., Sherr L. Combination therapies for HIV and sexual risk behavior among gay men. J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):266–271. doi: 10.1097/00126334-200003010-00010. [DOI] [PubMed] [Google Scholar]
  5. Gollub E. L., Rey D., Obadia Y., Moatti J. P. Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group. Sex Transm Dis. 1998 Oct;25(9):483–488. doi: 10.1097/00007435-199810000-00008. [DOI] [PubMed] [Google Scholar]
  6. Hankins C., Gendron S., Tran T., Lamping D., Lapointe N. Sexuality in Montreal women living with HIV. AIDS Care. 1997 Jun;9(3):261–271. doi: 10.1080/713613156. [DOI] [PubMed] [Google Scholar]
  7. Hecht F. M., Grant R. M., Petropoulos C. J., Dillon B., Chesney M. A., Tian H., Hellmann N. S., Bandrapalli N. I., Digilio L., Branson B. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med. 1998 Jul 30;339(5):307–311. doi: 10.1056/NEJM199807303390504. [DOI] [PubMed] [Google Scholar]
  8. Ickovics J. R., Morrill A. C., Beren S. E., Walsh U., Rodin J. Limited effects of HIV counseling and testing for women. A prospective study of behavioral and psychological consequences. JAMA. 1994 Aug 10;272(6):443–448. [PubMed] [Google Scholar]
  9. Kelly J. A., Hoffman R. G., Rompa D., Gray M. Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex. AIDS. 1998 Jul 9;12(10):F91–F95. doi: 10.1097/00002030-199810000-00001. [DOI] [PubMed] [Google Scholar]
  10. Kelly J. A., Murphy D. A., Bahr G. R., Koob J. J., Morgan M. G., Kalichman S. C., Stevenson L. Y., Brasfield T. L., Bernstein B. M., St Lawrence J. S. Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with human immunodeficiency virus (HIV) infection. Health Psychol. 1993 May;12(3):215–219. doi: 10.1037//0278-6133.12.3.215. [DOI] [PubMed] [Google Scholar]
  11. Kelly J. A., Otto-Salaj L. L., Sikkema K. J., Pinkerton S. D., Bloom F. R. Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention. Health Psychol. 1998 Jul;17(4):310–319. doi: 10.1037//0278-6133.17.4.310. [DOI] [PubMed] [Google Scholar]
  12. Kline A., VanLandingham M. HIV-infected women and sexual risk reduction: the relevance of existing models of behavior change. AIDS Educ Prev. 1994 Oct;6(5):390–402. [PubMed] [Google Scholar]
  13. Kravcik S., Victor G., Houston S., Sutherland D., Garber G. E., Hawley-Foss N., Angel J. B., Cameron D. W. Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):124–129. doi: 10.1097/00042560-199810010-00004. [DOI] [PubMed] [Google Scholar]
  14. Marks G., Ruiz M. S., Richardson J. L., Reed D., Mason H. R., Sotelo M., Turner P. A. Anal intercourse and disclosure of HIV infection among seropositive gay and bisexual men. J Acquir Immune Defic Syndr. 1994 Aug;7(8):866–869. [PubMed] [Google Scholar]
  15. Perry M. J., Solomon L. J., Winett R. A., Kelly J. A., Roffman R. A., Desiderato L. L., Kalichman S. C., Sikkema K. J., Norman A. D., Short B. High risk sexual behavior and alcohol consumption among bar-going gay men. AIDS. 1994 Sep;8(9):1321–1324. doi: 10.1097/00002030-199409000-00016. [DOI] [PubMed] [Google Scholar]
  16. Robins A. G., Dew M. A., Kingsley L. A., Becker J. T. Do homosexual and bisexual men who place others at potential risk for HIV have unique psychological profiles? AIDS Educ Prev. 1997 Jun;9(3):239–251. [PubMed] [Google Scholar]
  17. Robles R. R., Marrero C. A., Matos T. D., Colón H. M., Finlinson H. A., Reyes J. C., Sahai H. Factors associated with changes in sex behaviour among drug users in Puerto Rico. AIDS Care. 1998 Jun;10(3):329–338. doi: 10.1080/713612417. [DOI] [PubMed] [Google Scholar]
  18. Samuels J. F., Vlahov D., Anthony J. C., Chaisson R. E. Measurement of HIV risk behaviors among intravenous drug users. Br J Addict. 1992 Mar;87(3):417–428. doi: 10.1111/j.1360-0443.1992.tb01942.x. [DOI] [PubMed] [Google Scholar]
  19. Semaan S., Kotranski L., Collier K., Lauby J., Halbert J., Feighan K. Temporal trends in HIV risk behaviors of out-of-treatment injection drug users and injection drug users who smoke crack. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 1;19(3):274–281. doi: 10.1097/00042560-199811010-00010. [DOI] [PubMed] [Google Scholar]
  20. Strathdee S. A., Palepu A., Cornelisse P. G., Yip B., O'Shaughnessy M. V., Montaner J. S., Schechter M. T., Hogg R. S. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998 Aug 12;280(6):547–549. doi: 10.1001/jama.280.6.547. [DOI] [PubMed] [Google Scholar]
  21. Vanable P. A., Ostrow D. G., McKirnan D. J., Taywaditep K. J., Hope B. A. Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health Psychol. 2000 Mar;19(2):134–145. doi: 10.1037//0278-6133.19.2.134. [DOI] [PubMed] [Google Scholar]
  22. Wainberg M. A., Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998 Jun 24;279(24):1977–1983. doi: 10.1001/jama.279.24.1977. [DOI] [PubMed] [Google Scholar]
  23. Watkins K. E., Metzger D., Woody G., McLellan A. T. Determinants of condom use among intravenous drug users. AIDS. 1993 May;7(5):719–723. doi: 10.1097/00002030-199305000-00017. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES